Genitourinary medicine and sexually transmitted infections in the 21st century

International Journal of STD and AIDS

Volumn 11, Issue 1, 2000, Pages 1-7

  Thin, R N T ^a,b  

^a GUY'S AND ST THOMAS' NHS FOUNDATION TRUST   (United Kingdom)

^b ST THOMAS HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

HUMAN; NATIONAL HEALTH SERVICE; PRIORITY JOURNAL; REVIEW; SEXUALLY TRANSMITTED DISEASE; UNITED KINGDOM;

FEMALE; GYNECOLOGY; HEALTH SERVICES ACCESSIBILITY; HUMANS; MALE; NATIONAL HEALTH PROGRAMS; SEXUALLY TRANSMITTED DISEASES; UROLOGY;

EID: 0033984642     PISSN: 09564624     EISSN: None     Source Type: Journal    
DOI: 10.1258/0956462001914779     Document Type: Review

References (49)

1. Thin RNT. Genitourinary medicine and sexually transmitted diseases in the 1990s. Int J STD AIDS 1990;1:2-6
2. Department of Health. Report of the Working Group to Examine Workloads in Genitourinary Medicine Clinics. London: Department of Health, 1988
3. Department of Health and the Welsh Office. Health Building Note 12, Supplement 1, Genito Urinary Medicine Clinics. London: Department of Health, 1990
4. Royal College of Physicians. Consultant Physicians Working for Patients. London: Royal College of Physicians, 1999
5. Department of Health and Social Security. On the State of the Public Health; Report of the Chief Medical Officer of the Department of Health and Social Security for the Year 1984. London: HMSO, 1985
6. Sutton A, Kingsland T, Ross S, Burke M, Gray T, Jenkins J. Nursing in genitourinary medicine: 10 years on from the Monks Report. Int J STD AIDS 1999;10:539-42
7. Hughes G, Simms I, Rogers PA, Swan AV, Catchpole M. New cases seen at genitourinary medicine clinics: England 1997. Commun Dis Rep 1998;8(suppl 7):S1-S12
8. Department of Health. The Health of the Nation. London: Department of Health, 1992
9. Thin RN, Basu Roy R. Genitourinary medicine in the next millennium. Int J STD AIDS 1998;9:180-2
10. Department of Health. Our Healthier Nation; A Consultation Paper. London: Department of Health, 1998:22
11. Department of Health Press Release. First Ever Government Strategy on Sexual Health Launched (1999/0166). London: Department of Health, 1999
12. Department of Health. The New NHS; Modern, Dependable. London: Department of Health, 1997
13. Gazzard BG, Moyle GJ, Weber J, et al. (BHIVA Guidelines Co-ordinating Committee). British Guidelines for antiretroviral treatment of HIV seropositive individuals. Lancet 1997;349:1086-91
14. Radcliffe K, Ahmed-Jushuf I, Cowan F, Fitzgerald M, Wilson J. UK national guidelines on sexually transmitted infections and closely allied conditions. Sex Transm Infect 1999;75(suppl 1)
15. Godley MJ. Report of the first annual general meeting of the Association for Genituourinary Medicine. Int J STD AIDS 1994;5:225-9
16. Philpot R. IUSTI (Previously IUVDT). World Secretary General's Report. Int J STD AIDS 1998;9:305-7
17. Shahmanesh M. More transparency, greater depth (Editorial). Sex Transm Infect 1998;74:4-5
18. Fauci AS. The AIDS epidemic; considerations for the 21st century. New Engl J Med 1999;341:1046-50
19. Evans B. Third era surveillance of HIV infection and disease. Document for HIV Surveillance Meeting. Ottawa, September 1999
20. Youle M, Weston R, Trueman P, Swaden L, Leake H. Perfect combination. Health Service J 1999;109:26-7
21. Arvin A, Prober CG. Herpes simplex virus type 2 - a persistent problem. New Engl J Med, 1997;337:1158-9
22. Waldhuber MG, Denham I, Wadey C, Leong-Shaw W, Cross GF. Detection of herpes simplex virus in genital specimens by type-specific polymerase chain reaction. Int J STD AIDS 1999;10:89-92
23. Consumer Association. Update on drugs for herpes zoster and genital herpes. Drug Therapeut Bull 1998;36:77-9
24. Wald A, Zeh J, Barnum J, et al. Suppression of sub-clinical shedding of herpes simplex virus type 2 with acyclovir. Ann Intern Med 1996;124:8-15
25. Kinghorn GR. Type specific serological testing for herpes simplex infection. Int J STD AIDS 1998;9:497-500
26. Mehta D, Martin J, Donyai P, et al. Imiquimod, Podophyllotoxin, Vol. 38. British National Formulary, London: BMJ Books, and Wallingford, Pharmaceutical Press, 1999:513
27. Borisenko KK, Tichonova LI, Renton AM. Syphilis and other sexually transmitted infections in the Russian Federation. Int J STD AIDS 1999;10:665-8
28. Annotation. Sexually transmitted diseases quarterly report: syphilis - national and international epidemiology. Commun Dis Rep 1999;9:38-9
29. Annotation. Enhanced surveillance for heterosexually acquired syphilis in London and the former North East Thames Region. Commun Dis Rep 1999;9:269
30. Larsen SA, Steiner BM, Rudolph AH. Laboratory diagnosis and interpretation of tests for syphilis. Clin Microbiol Rev 1995;8:1-6
31. Fraser CM, Norris SJ, Weinstock GM, et al. Complete genome sequence of Treponema pallidum, the syphilis spirochaete. Science 1998;281:375-88
32. Department of Health. Sexually Transmitted Diseases, England 1995; New Cases seen at NHS Genito-Urinary Medicine Clinics (Statistical Bulletin). London: Government Statistical Service, 1996
33. Expert Advisory Group on Chlamydia trachomatis. Report on Chlamydia trachomatis. London: Department of Health, 1998
34. Davies PO, Ridgway GL. The role of polymerase chain reaction and ligase chain reaction for the detection of Chlamydia trachomatis. Int J STD AIDS 1997;8:731-8
35. Black CM. Current methods of laboratory diagnosis of Chlamydia trachomatis infections. Clin Microbiol Rev 1997; 10:160-84
36. Mehta D, Martin J, Donyai P, et al., eds. Azithromycin, Vol. 38. British National Formulary. London: BMJ Books, and Wallingford Pharamceutical Press, 1999:261
37. Fleming DT, Wasserheit JN. From epidemiological synergy to public health policy and practice: the contribution of other sexually transmitted diseases to sexual transmission of HIV infection. Sex Transm Inf 1999;75:3-17
38. Martin JN, Ganem DE, Osmond DH, Page-Shafer KA, Macrae D, Kedes DH. Sexual transmission and the natural history of human herpesvirus 8 infection. New Engl J Med 1998;338:948-54
39. Llahi-Camp JM, Ison CA, Regan L, Taylor Robinson D. The association of bacterial vaginosis with a history of second trimester miscarriage. Int J STD AIDS 1997;8(supp 1):S27-S29
40. French JI, McGregor JA, Draper D, Parker R, McFee J. Early gestational bleeding, bacterial vaginosis and infections of the lower reproductive tract increase risks of preterm birth. Int J STD AIDS 1997;8(suppl 1):S30-S31
41. Taylor Robinson D. Introduction to non-pregnancy complications of bacterial vaginosis. Int J STD AIDS 1997;8(suppl 1):S17-S19
42. MacLennan A. A template for defining a causal relation between acute intrapartum events and cerebral palsy: international consensus statement. BMJ 1999;319:1054-9
43. Poljak M, Brencic A, Seme K, Vince A, Marin IJ. Comparative evaluation of first- and second-generation digene hybrid capture assays for detection of human papilloma viruses associated with high or intermediate risk for cervical cancer. J Clin Microbiol 1999;37:796-7
44. Thompson HSG, Davies ML, Holding FP, et al. Phase 1 safety and antigenicity of TA-GW; a recombinant HPV6L2/ E7 vaccine for the treatment of genital warts. Vaccine 1998;17:40-9
45. Walker J, Leib DA. Protection from primary infection and establishment of latency by vaccination with a herpes simplex virus type 1 recombinant deficient in the virion shutoff function. Vaccine 1998;16:1-5
46. Collins KL, Nabel GJ. Naturally attenuated HIV - lessons for AIDS vaccines and treatment. New Engl J Med 1999;340: 1756-7
47. Ward SG, Bacon K, Westwick J. Chemokines and T lymphocytes: more than an attraction. Immunity 1998;9:1-11
48. Rowland-Jones S. The role of chemokine receptors in HIV infection. Sex Transm Infect 1999;75:148-51
49. Haynes BF. New frontiers of immunotherapy for HIV. Lancet 1996;348:1531-2